Literature DB >> 1824886

Degree of modulation of cell-surface CD3 by anti-lymphocyte therapies.

K R Henell1, A Bakke, T A Kenny, J A Kimball, J M Barry, D J Norman.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1824886

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts.

Authors:  Jing Li; Bo Zhou; Jianzhong Shentu; Li Du; Min Tan; Sheng Hou; Weizhu Qian; Bohua Li; Dapeng Zhang; Jianxin Dai; Hao Wang; Xu Zhang; Jianghua Chen; Yajun Guo
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

2.  TGN1412 Induces Lymphopenia and Human Cytokine Release in a Humanized Mouse Model.

Authors:  Sabrina Weißmüller; Stefanie Kronhart; Dorothea Kreuz; Barbara Schnierle; Ulrich Kalinke; Jörg Kirberg; Kay-Martin Hanschmann; Zoe Waibler
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.